1. Home
  2. BSRR vs PRME Comparison

BSRR vs PRME Comparison

Compare BSRR & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sierra Bancorp

BSRR

Sierra Bancorp

HOLD

Current Price

$38.10

Market Cap

479.7M

Sector

Finance

ML Signal

HOLD

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$2.99

Market Cap

536.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSRR
PRME
Founded
1977
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
479.7M
536.4M
IPO Year
2001
2022

Fundamental Metrics

Financial Performance
Metric
BSRR
PRME
Price
$38.10
$2.99
Analyst Decision
Buy
Buy
Analyst Count
3
6
Target Price
$37.00
$7.56
AVG Volume (30 Days)
46.6K
2.2M
Earning Date
04-27-2026
05-08-2026
Dividend Yield
2.93%
N/A
EPS Growth
10.28
18.18
EPS
0.96
N/A
Revenue
N/A
$4,632,000.00
Revenue This Year
$11.74
$7.06
Revenue Next Year
$3.63
$47.01
P/E Ratio
$39.70
N/A
Revenue Growth
N/A
55.28
52 Week Low
$26.49
$1.18
52 Week High
$38.87
$6.94

Technical Indicators

Market Signals
Indicator
BSRR
PRME
Relative Strength Index (RSI) 59.54 39.24
Support Level $36.00 N/A
Resistance Level $38.45 $3.97
Average True Range (ATR) 0.89 0.24
MACD 0.05 -0.03
Stochastic Oscillator 75.53 31.15

Price Performance

Historical Comparison
BSRR
PRME

About BSRR Sierra Bancorp

Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. it offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

Share on Social Networks: